CCL Biomedical Overview

  • Founded
  • 2002
  • Status
  • Out of Business
  • Employees
  • 3
  • Latest Deal Type
  • Out of Business

CCL Biomedical General Information


Developer of antimicrobial compounds intended to be used for combatting serious health issues and reducing the number of infections and deaths. The company's antimicrobial compounds helps in effective destruction of micro-organisms and biofilm control, enabling clients to avail effective products to address their individual needs.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Healthcare Services
Primary Office
  • Havre de Grace, MD 21078
  • United States
+1 (240) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CCL Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Apr-2018 Completed Out of Business
5. Later Stage VC Completed Generating Revenue
4. Grant 01-Jan-2013 00000 Completed Generating Revenue
3. Grant 01-Jan-2009 00000 Completed Generating Revenue
2. Grant 01-Jan-2007 $600K Completed Generating Revenue
1. Grant 01-Jan-2003 $270K Completed Generating Revenue
To view CCL Biomedical’s complete valuation and funding history, request access »

CCL Biomedical Executive Team (2)

Name Title Board Seat Contact Info
Stuart Cooper Co-Founder
You’re viewing 1 of 2 executive team members. Get the full list »

CCL Biomedical Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial